Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Ayad

Showing results (71-80 of 78) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 78 results.
EMBO Reports|August 31, 2023
Loss of BRD4 induces cell senescence in HSC/HPCs by deregulating histone H3 clippingHui Yang, Pinpin Sui, Ying Guo, et al.
Neuro-Oncology Advances|February 4, 2022
A multiparametric pharmacogenomic strategy for drug repositioning predicts therapeutic efficacy for glioblastoma cell linesAshish H Shah, Robert Suter, Pavan Gudoor, et al.
Cell Reports|April 7, 2015
Casein kinase 1δ is an APC/C(Cdh1) substrate that regulates cerebellar granule cell neurogenesisClara Penas, Eve-Ellen Govek, Yin Fang, et al.
Nature Communications|September 7, 2021
The E3 ubiquitin ligase component, Cereblon, is an evolutionarily conserved regulator of Wnt signalingChen Shen, Anmada Nayak, Leif R Neitzel, et al.
Nature Communications|December 16, 2018
Drug and disease signature integration identifies synergistic combinations in glioblastomaVasileios Stathias, Anna M Jermakowicz, Marie E Maloof, et al.
Nature Communications|January 7, 2026
Drug and single-cell gene expression integration identifies sensitive and resistant glioblastoma cell populationsRobert K Suter, Anna M Jermakowicz, Rithvik Veeramachaneni, et al.
Biorxiv : the Preprint Server for Biology|June 4, 2025
DRUG AND SINGLE-CELL GENE EXPRESSION INTEGRATION IDENTIFIES SENSITIVE AND RESISTANT GLIOBLASTOMA CELL POPULATIONSRobert K Suter, Anna M Jermakowicz, Rithvik Veeramachaneni, et al.
The Journal of Clinical Investigation|June 17, 2024
Triptolide and its prodrug Minnelide target high-risk MYC-amplified medulloblastoma in preclinical modelsJezabel Rodriguez-Blanco, April D Salvador, Robert K Suter, et al.
Pageof 8

Showing results (71-80 of 78) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 78 results.
EMBO Reports|August 31, 2023
Loss of BRD4 induces cell senescence in HSC/HPCs by deregulating histone H3 clippingHui Yang, Pinpin Sui, Ying Guo, et al.
Neuro-Oncology Advances|February 4, 2022
A multiparametric pharmacogenomic strategy for drug repositioning predicts therapeutic efficacy for glioblastoma cell linesAshish H Shah, Robert Suter, Pavan Gudoor, et al.
Cell Reports|April 7, 2015
Casein kinase 1δ is an APC/C(Cdh1) substrate that regulates cerebellar granule cell neurogenesisClara Penas, Eve-Ellen Govek, Yin Fang, et al.
Nature Communications|September 7, 2021
The E3 ubiquitin ligase component, Cereblon, is an evolutionarily conserved regulator of Wnt signalingChen Shen, Anmada Nayak, Leif R Neitzel, et al.
Nature Communications|December 16, 2018
Drug and disease signature integration identifies synergistic combinations in glioblastomaVasileios Stathias, Anna M Jermakowicz, Marie E Maloof, et al.
Nature Communications|January 7, 2026
Drug and single-cell gene expression integration identifies sensitive and resistant glioblastoma cell populationsRobert K Suter, Anna M Jermakowicz, Rithvik Veeramachaneni, et al.
Biorxiv : the Preprint Server for Biology|June 4, 2025
DRUG AND SINGLE-CELL GENE EXPRESSION INTEGRATION IDENTIFIES SENSITIVE AND RESISTANT GLIOBLASTOMA CELL POPULATIONSRobert K Suter, Anna M Jermakowicz, Rithvik Veeramachaneni, et al.
The Journal of Clinical Investigation|June 17, 2024
Triptolide and its prodrug Minnelide target high-risk MYC-amplified medulloblastoma in preclinical modelsJezabel Rodriguez-Blanco, April D Salvador, Robert K Suter, et al.
Pageof 8